gabexate has been researched along with Rhinitis in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Rhinitis: Inflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fundueanu, G | 1 |
| Constantin, M | 1 |
| Dalpiaz, A | 1 |
| Bortolotti, F | 1 |
| Cortesi, R | 1 |
| Ascenzi, P | 1 |
| Menegatti, E | 1 |
1 other study available for gabexate and Rhinitis
| Article | Year |
|---|---|
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy) in allergic rhinitis treatment.
Topics: Adhesives; Administration, Intranasal; Animals; Coated Materials, Biocompatible; Contraceptive Agent | 2004 |